• SENSEX 82,031.81
    -500.38 (--0.61%)
  • BANKNIFTY 62,038.65
    -234.60 (--0.38%)
  • IIFL Finance
    682.40 704.90(%)
  • NSE
    2,113.70 2,134.00(%)
  • Coforge
    2,060.00 2,127.30(%)
  • SBI
    1,142.00 1,234.80(%)
  • Reliance Industries
    1,354.00 1,152.30(%)
  • Billionbrains
    222.40 142.05(%)
  • Urban Company
    173.90 183.65(%)
  • Eternal
    365.10 212.55(%)
  • Cummins India
    3,968.00 3,883.30(%)
  • ITC
    298.00 410.95(%)
  • Bharat Forge
    1,683.00 1,328.15(%)
  • V2 Retail
    122.70 122.70(%)
  • Greenlam Industr
    231.55 280.60(%)
  • ICICI Bank
    1,610.00 1,616.70(%)
  • Axis Bank
    1,356.80 1,150.50(%)
  • Polycab India
    7,294.50 6,660.50(%)
  • Adani Energy Sol
    1,460.00 804.70(%)
  • Lalithaa Jewel
    314.20 240.30(%)
  • Bajaj Finance
    1,089.55 788.40(%)
  • Tata Motors
    436.00 308.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Solara Active Pharma Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
650.50 -16 (-2.37%)
  • As on 18 Nov 2026 (EOD)
  • Today’s Low

    645.75
  • Today’s High

    674.95
  • Open

    666.60
  • Perv Close

    666.30
  • 52W Low

    422.00
  • 52W High

    774.00

Key Indicators

  • P/E(TTM)

    64.04

  • Mar.Cap (₹Cr.)

    3,157.56

  • Div & Yield %

    0.00

  • Book Value(₹)

    296.85

  • Debt-Equity Ratio

    -2.37

  • AGM Date

    18-Nov-2026

  • EPS

    10.16

  • P/E Ratio

    64.04

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    3,157.56

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    48.54

  • BV (₹)

    296.90

  • Sales( ₹ in Cr.)

    1,368.98

  • NP (in Cr.)

    -1.35

  • NP Var(%)

    -25.0

  • Div%

    0.0

  • CPS (₹)

    20.30

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    3,158.29

  • 52 Week High

    774.00

  • 52 Week Low

    422.00

  • Price BSE

    651.0

  • Price NSE

    651.00

  • Market Capital( in Cr.)

    3,158.29

  • P/C Ratio

    32.10

  • P/E Ratio

    -2,340.70

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,368.98 1,283.76 1,288.92 1,443.81 1,268.34 1,616.88
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,368.98 1,283.76 1,288.92 1,443.81 1,268.34 1,616.88
Other Income 5.89 9.14 5.37 22.14 18.76 28.41
Stock Adjustments -8.25 -39.00 -39.27 -7.05 258.75 2.15
Total Income 1,366.62 1,253.90 1,255.02 1,458.90 1,545.85 1,647.44
EXPENDITURE :            
Raw Materials 676.26 587.41 765.75 781.78 912.64 726.56
Power and Fuel Cost 98.47 94.37 122.56 107.95 93.70 85.42
Employee Cost 223.80 214.75 246.57 228.05 234.20 227.63
Other Manufacturing Expenses 92.81 67.80 109.31 90.76 97.87 91.19
Selling and Administration Expenses 64.48 59.10 70.40 67.50 76.39 76.07
Miscellaneous Expenses 28.72 20.56 222.41 26.68 35.43 26.83
Employee Benefit Expenses 223.80 214.75 246.57 228.05 234.20 227.63
Less: Preoperative Expenditure 4.60 3.07 2.65 0.00 0.00 0.00
Total Expenses 1,179.94 1,040.92 1,534.35 1,302.72 1,450.23 1,233.70
Operating Profit 186.68 212.98 -279.33 156.18 95.62 413.74
Interest 94.24 114.81 105.97 90.06 75.27 84.47
Gross Profit 92.44 98.17 -385.30 66.12 20.35 329.27
Depreciation 99.68 99.25 103.03 110.90 112.01 108.31
Profit Before Tax -7.24 -1.08 -488.33 -44.78 -91.66 220.96
Current Tax 0.00 0.00 0.00 -0.11 0.00 38.64
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 78.54 -22.46 -33.10 -38.64
Reported Net Profit -7.24 -1.08 -566.87 -22.21 -58.56 220.96
Extraordinary Items -5.89 0.00 -158.84 -0.45 -4.26 1.65
Adjusted Net Profit -1.35 -1.08 -408.03 -21.76 -54.30 219.31
Adjustment below Net Profit 0.00 0.00 0.56 -1.76 2.01 -2.53
P & L Balance brought forward -296.16 -295.37 250.04 274.01 341.34 142.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -0.44 -0.29 0.00 0.00 10.78 19.74
P & L Balance carried down -302.96 -296.16 -316.27 250.04 274.01 341.34
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 30.00 0.00 70.00
Dividend Per Share(Rs) 0.00 0.00 0.00 3.00 0.00 7.00
Earnings Per Share-Unit Curr -1.63 -0.27 -157.46 -6.17 -16.27 61.50
Earnings Per Share(Adj)-Unit Curr -1.63 -0.27 -145.12 -5.69 -15.00 56.68
Book Value 282.06 272.35 260.39 417.54 424.18 443.30
Book Value(Adj)-Unit Curr 282.06 272.35 239.98 384.83 390.94 408.56

Shareholding Pattern

  • Promoter Group

    41.93%

  • Public Share Holding

    58.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 16,306,480 33.80 16,306,480 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,401,417 7.05 3,401,417 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 523,384 1.08 523,384 1
Others 0 0.00 0 0
Sub Total 20,231,281 41.93 20,231,281 19
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,354 0.00 1,354 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,308 0.00 1,308 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,167,752 10.71 5,167,752 63
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 421,071 0.87 421,071 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,456,248 3.02 1,456,248 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,047,733 14.61 7,047,733 76
2] Non Institution
Bodies Corporate 4,331,148 8.98 4,329,496 473
Clearing Members 76 0.00 76 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 608,747 1.26 607,434 1,703
Foreign Non Institution Other 3,500 0.01 3,500 1
Hindu Undivided Families 550,193 1.14 550,100 1,521
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,593,159 7.45 3,593,159 68
Individuals holding nominal share capital up to Rs. 1 lakh 9,733,810 20.17 9,713,084 66,963
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 9,094 0.02 9,094 2
Others 83,949 0.17 83,949 3
Sub Total 20,971,498 43.46 20,947,714 70,810
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,250,512 100.00 48,226,728 70,905

Company Background

Solara Active Pharma Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Solara Active Pharma Sciences Ltd
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
  • Incorporation Year

    2017

  • Registered Office

    201 Devavrata Sector 17 Vashi
    Navi Mumbai, Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924

  • FAX

    91-22-27892942

  • Chairman

    Ramakrishnan Rajagopal

  • Managing Director

    Sandeep Rao

  • Company Secretary

    Pooja Jaya Kumar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Solara Active Pharma Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Solara Active 650.65 1,374.87 1,368.98 81.13 0.00
Abbott India 25,490.90 7,217.19 6,929.05 32.77 43.78
Astrazeneca Phar 6,006.95 2,304.07 2,275.58 84.50 27.86
Glaxosmi. Pharma 2,638.00 3,932.76 3,790.20 39.20 58.17
Cipla 1,420.00 20,102.60 18,979.95 43.28 13.88
Evonile Pharma 1,411.75 393.10 354.33 -1,238.38 15.94
Bliss GVS Pharma 674.30 773.53 729.81 43.96 12.51
Amrutanjan Healt 515.90 520.13 502.55 26.03 24.16
Fermenta Biotec. 455.60 474.15 450.25 21.53 18.77
Guj. Themis Bio. 361.60 168.25 165.82 109.58 18.05
Ambalal Sarabhai 39.00 19.52 3.94 66.10 6.77